Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.
Otixal is an antibiotic and steroid combination ear drop.
Health Canada approves Pediapharm ear infection drug
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Health Canada approves Pediapharm ear infection drug
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals